Al-Rad Companion (Musculoskeletal)
Siemens Medical Solutions USA, Inc. • Radiology • 03/16/2020
Device Purpose
The AI-Rad Companion (Musculoskeletal) is a software tool that employs deep learning for automated analysis of CT images to aid in assessing musculoskeletal conditions in adult patients. Its methodology involves a 3D Deep Image-to-Image network for segmenting vertebrae, labeling them, measuring heights, and calculating Hounsfield Unit values, thereby providing quantitative and qualitative support for clinical decision-making.
Summary
The AI-Rad Companion (Musculoskeletal) is an image processing software designed to support radiologists and physicians in the evaluation and assessment of musculoskeletal disease in adult patients. It analyzes previously acquired Computed Tomography (CT) DICOM images, providing both quantitative and qualitative data. Key functionalities include the segmentation and labeling of vertebrae, measurement of heights in each vertebra with an indication if they are critically different, and the measurement of mean Hounsfield Unit (HU) values within a volume of interest in the vertebra. This tool aims to enhance diagnostic workflows in settings like emergency medicine, specialty care, urgent care, and general practice. The software operates as a post-processing application utilizing deep learning algorithms, specifically a 3D Deep Image-to-Image network based on a convolutional encoder-decoder architecture, to process CT data of the thorax for musculoskeletal analysis. This technology, similar to that in the AI-Rad Companion (Cardiovascular), automates tasks like vertebra segmentation and height measurements, including comparisons based on Genant criteria, which were manual in predicate devices. Clinical performance, validated through a retrospective study on 140 chest CT datasets, demonstrated high agreement with manual radiologist assessments, with 95.1% of vertebral height measurements on thin slices and 98.8% of vertebral density measurements falling within the 95% limits of agreement of ground truth.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How does the performance of the deep learning-based segmentation in AI-Rad Companion (Musculoskeletal) compare to the model-based segmentation of its predicate device in terms of accuracy, processing time, and robustness across diverse patient populations with varying bone densities?; What specific Genant criteria are automatically applied for vertebral height comparisons, and how is the threshold for 'critically different' heights determined, validated, and can it be customized by the user?; The clinical performance data indicates a variance in accuracy for vertebra height measurements between thin (≤1 mm) and thicker (>1 mm) slices (95.1% vs 87.5%). What are the technical factors contributing to this difference, and what are the implications for image acquisition protocols?; How does the 3D Deep Image-to-Image network handle challenging anatomical variations or significant pathological changes in vertebrae (e.g., severe osteophytes, compression fractures, lytic lesions) that might impact segmentation accuracy and subsequent measurements?; What is the range of Hounsfield unit values the software is validated for, and how does it account for potential variabilities in HU values due to different CT scanner calibrations or reconstruction kernels?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM, SaaSBOM detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: SBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly